financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Viatris Fined $1.9 Million Over Alleged Violation of Antitrust Restrictions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Viatris Fined $1.9 Million Over Alleged Violation of Antitrust Restrictions
Nov 22, 2024 6:24 AM

09:02 AM EST, 11/22/2024 (MT Newswires) -- Viatris ( VTRS ) has been fined 1.5 million UK pounds ($1.9 million) by the UK's Competition and Markets Authority for failing to comply with an order obtaining government approval before making staff changes and failing to report the breach, the regulator said Friday.

The penalty was imposed in response to Viatris' ( VTRS ) sale of the European right to its hormone replacement therapy treatments Duphaston and Femoston to Theramex, which the regulator said could reduce competition.

The regulator said Viatris ( VTRS ) breached restrictions imposed on it during an investigation by "implementing changes to key members of its UK management team" without consent and failing to notify authorities of the breach.

Viatris ( VTRS ) did not immediately reply to MT Newswires' request for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Model N to Be Acquired by Vista Equity Partners for $1.25 Billion in Cash
Model N to Be Acquired by Vista Equity Partners for $1.25 Billion in Cash
Apr 8, 2024
08:22 AM EDT, 04/08/2024 (MT Newswires) -- Vista Equity Partners has entered into a definitive merger agreement to acquire Model N ( MODN ) , for $1.25 billion in an all-cash transaction, Model N ( MODN ) said Monday. Price: 29.49, Change: +2.4, Percent Change: +8.86 ...
 Johnson & Johnson, Legend Biotech's Carvykti Receives FDA Approval to Treat Relapsed, Refractory Multiple Myeloma
Johnson & Johnson, Legend Biotech's Carvykti Receives FDA Approval to Treat Relapsed, Refractory Multiple Myeloma
Apr 8, 2024
08:22 AM EDT, 04/08/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) and Legend Biotech ( LEGN ) said the US Food and Drug Administration has approved Carvykti to treat adults with relapsed or refractory multiple myeloma who have received at least one prior line of therapy. In 2017, Legend entered into a worldwide license and collaboration agreement with...
 Blackstone to take Apartment Income REIT private for $10 bln, WSJ reports
Blackstone to take Apartment Income REIT private for $10 bln, WSJ reports
Apr 8, 2024
April 8 (Reuters) - Asset manager Blackstone is taking private rental housing firm Apartment Income REIT ( AIRC ) , known as AIR Communities, for $10 billion in cash, the Wall Street Journal reported on Monday, citing people familiar with the matter. (Reporting by Ananta Agarwal in Bengaluru; Editing by Arun Koyyur) ...
 Boeing Says Departing Chief Executive Received $32.8 Million Pay Package in 2023
Boeing Says Departing Chief Executive Received $32.8 Million Pay Package in 2023
Apr 8, 2024
08:21 AM EDT, 04/08/2024 (MT Newswires) -- Boeing's ( BA ) departing Chief Executive David Calhoun received a total compensation of about $32.8 million in 2023, up from his $22.6 million pay package in 2022, according to a regulatory filing Friday. Calhoun, who announced his resignation from the company in March amid concerns about Boeing ( BA ) planes' quality,...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved